HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Affinity of 3-beta-(2-hydroxyethoxy)-5-alpha-cholest-8(14)-ene-15-one to oxysterol binding protein and its metabolism in HepG2 hepatoma cells].

Abstract
beta-(2-Hydroxyethoxy)-5 alpha-cholest-8(14)-en-15-one, a synthetic inhibitor of cholesterol biosynthesis, was shown to exhibit a high affinity to oxysterol binding protein. This was proved by ultracentrifugation of the protein fraction from rabbit liver in the presence of the 3H-labeled inhibitor, 3 beta-(2-hydroxy-2-[3H]ethoxy)-5 alpha-cholest-8(14)-en-15-one, or by the substitution of the [3H]-25-hydroxycholesterol in its complex with the oxysterol binding protein. In human hepatoma Hep G2 cells, the inhibitor decreased activity of 3-hydroxy-3-methylglutaryl CoA reductase [ID50 (2.7 +/- 0.7) x 10(-5) M] and was transformed into 3 beta-[2-(9-Z-octadecenoyloxy)ethoxy]-5 alpha-cholest-8(14)-en-15-one.
AuthorsA Iu Misharin, A S Krylov, C Alquier, H LaFont, A Ia Shteĭnshneĭder, V A Kosykh, A D Morozkin
JournalBioorganicheskaia khimiia (Bioorg Khim) Vol. 23 Issue 4 Pg. 297-303 (Apr 1997) ISSN: 0132-3423 [Print] Russia (Federation)
Vernacular TitleSrodstvo 3beta-(2-gidroksiétoksi)-5alpha-kholest-8(14)-en-15-ona k oksisterinsviazyvaiushchemu belku i ego metabolizm v kletkakh gepatomy HepG2.
PMID9221731 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Receptors, Steroid
  • oxysterol binding protein
  • cholest-8(14)-ene-3,26-diol-15-one
  • Cholesterol
Topics
  • Animals
  • Carcinoma, Hepatocellular (enzymology, metabolism, pathology)
  • Cholesterol (analogs & derivatives, metabolism)
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Liver Neoplasms (enzymology, metabolism, pathology)
  • Rabbits
  • Receptors, Steroid (metabolism)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: